Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
The function of EMSY in cancer development.
Jing Hou1, Ziliang Wang, Lina Yang
1Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
The EMSY gene binds BRCA2, inactivating its function and promoting breast and ovarian cancers. EMSY amplification is also linked to prostate and pancreatic cancers, affecting tumor traits and outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The EMSY gene interacts with BRCA2, inhibiting its tumor-suppressive functions.
- EMSY's role in DNA damage repair, genomic instability, and chromatin remodeling is implicated in cancer.
- Amplification of EMSY has been observed in various cancers, including breast, ovarian, prostate, and pancreatic types.
Purpose of the Study:
- To review recent literature on the role of EMSY in cancer development.
- To summarize the association between EMSY and different cancer types.
- To highlight EMSY's impact on tumor phenotypes and clinical outcomes.
Main Methods:
- Literature review of studies published since 2003.
- Analysis of research on EMSY's interaction with BRCA2.
- Examination of studies linking EMSY amplification to various cancers.
Main Results:
- EMSY inactivation of BRCA2 is a key mechanism in sporadic breast and ovarian cancer.
- EMSY amplification correlates with adverse tumor phenotypes and clinical outcomes in prostate and pancreatic cancers.
- EMSY's functions extend to DNA repair, genomic stability, and chromatin regulation.
Conclusions:
- EMSY is a significant factor in the development and progression of multiple cancer types.
- Targeting EMSY may offer potential therapeutic strategies for various cancers.
- Further research into EMSY's multifaceted roles is warranted.
Related Concept Videos
Mitogens and the Cell Cycle
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

